BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

957 related articles for article (PubMed ID: 26140342)

  • 1. The safety of human pluripotent stem cells in clinical treatment.
    Simonson OE; Domogatskaya A; Volchkov P; Rodin S
    Ann Med; 2015; 47(5):370-80. PubMed ID: 26140342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic effect of medium, matrix, and exogenous factors on the adhesion and growth of human pluripotent stem cells under defined, xeno-free conditions.
    Meng G; Liu S; Rancourt DE
    Stem Cells Dev; 2012 Jul; 21(11):2036-48. PubMed ID: 22149941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induced pluripotent stem cells in regenerative medicine: an argument for continued research on human embryonic stem cells.
    Lee H; Park J; Forget BG; Gaines P
    Regen Med; 2009 Sep; 4(5):759-69. PubMed ID: 19761400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stable propagation of human embryonic and induced pluripotent stem cells on decellularized human substrates.
    Abraham S; Sheridan SD; Miller B; Rao RR
    Biotechnol Prog; 2010; 26(4):1126-34. PubMed ID: 20730767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Technological progress and challenges towards cGMP manufacturing of human pluripotent stem cells based therapeutic products for allogeneic and autologous cell therapies.
    Abbasalizadeh S; Baharvand H
    Biotechnol Adv; 2013 Dec; 31(8):1600-23. PubMed ID: 23962714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GMP scale-up and banking of pluripotent stem cells for cellular therapy applications.
    Ausubel LJ; Lopez PM; Couture LA
    Methods Mol Biol; 2011; 767():147-59. PubMed ID: 21822873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haematopoietic developmental potential of human pluripotent stem cell lines.
    Tesařová L; Simara P; Stejskal S; Koutná I
    Folia Biol (Praha); 2014; 60 Suppl 1():90-4. PubMed ID: 25369348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Derivation of human parthenogenetic stem cell lines.
    Turovets N; Semechkin A; Kuzmichev L; Janus J; Agapova L; Revazova E
    Methods Mol Biol; 2011; 767():37-54. PubMed ID: 21822866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human cardiomyocyte generation from pluripotent stem cells: A state-of-art.
    Talkhabi M; Aghdami N; Baharvand H
    Life Sci; 2016 Jan; 145():98-113. PubMed ID: 26682938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current applications of human pluripotent stem cells: possibilities and challenges.
    Ho PJ; Yen ML; Yet SF; Yen BL
    Cell Transplant; 2012; 21(5):801-14. PubMed ID: 22449556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of Differentiation Tendency Toward Hepatocytes from Gene Expression in Undifferentiated Human Pluripotent Stem Cells.
    Yanagihara K; Liu Y; Kanie K; Takayama K; Kokunugi M; Hirata M; Fukuda T; Suga M; Nikawa H; Mizuguchi H; Kato R; Furue MK
    Stem Cells Dev; 2016 Dec; 25(24):1884-1897. PubMed ID: 27733097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro culture and directed osteogenic differentiation of human pluripotent stem cells on peptides-decorated two-dimensional microenvironment.
    Wang M; Deng Y; Zhou P; Luo Z; Li Q; Xie B; Zhang X; Chen T; Pei D; Tang Z; Wei S
    ACS Appl Mater Interfaces; 2015 Mar; 7(8):4560-72. PubMed ID: 25671246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A massive suspension culture system with metabolic purification for human pluripotent stem cell-derived cardiomyocytes.
    Hemmi N; Tohyama S; Nakajima K; Kanazawa H; Suzuki T; Hattori F; Seki T; Kishino Y; Hirano A; Okada M; Tabei R; Ohno R; Fujita C; Haruna T; Yuasa S; Sano M; Fujita J; Fukuda K
    Stem Cells Transl Med; 2014 Dec; 3(12):1473-83. PubMed ID: 25355733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of Feeding Strategies on the Scalable Expansion of Human Pluripotent Stem Cells in Single-Use Stirred Tank Bioreactors.
    Kropp C; Kempf H; Halloin C; Robles-Diaz D; Franke A; Scheper T; Kinast K; Knorpp T; Joos TO; Haverich A; Martin U; Zweigerdt R; Olmer R
    Stem Cells Transl Med; 2016 Oct; 5(10):1289-1301. PubMed ID: 27369897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single cell heterogeneity in human pluripotent stem cells.
    Yang S; Cho Y; Jang J
    BMB Rep; 2021 Oct; 54(10):505-515. PubMed ID: 34488931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strand displacement amplification for ultrasensitive detection of human pluripotent stem cells.
    Wu W; Mao Y; Zhao S; Lu X; Liang X; Zeng L
    Anal Chim Acta; 2015 Jun; 881():124-30. PubMed ID: 26041528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The suspension culture of undifferentiated human pluripotent stem cells using spinner flasks.
    Chen VC; Couture LA
    Methods Mol Biol; 2015; 1283():13-21. PubMed ID: 25537838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Embryonic stem cells from blastomeres maintaining embryo viability.
    Klimanskaya I
    Semin Reprod Med; 2013 Jan; 31(1):49-55. PubMed ID: 23329636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Derivation of high-purity definitive endoderm from human parthenogenetic stem cells using an in vitro analog of the primitive streak.
    Turovets N; Fair J; West R; Ostrowska A; Semechkin R; Janus J; Cui L; Agapov V; Turovets I; Semechkin A; Csete M; Agapova L
    Cell Transplant; 2012; 21(1):217-34. PubMed ID: 21669044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical-scale purification of pluripotent stem cell derivatives for cell-based therapies.
    Rodrigues GM; Rodrigues CA; Fernandes TG; Diogo MM; Cabral JM
    Biotechnol J; 2015 Aug; 10(8):1103-14. PubMed ID: 25851544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.